Taylor-Fishwick, David A.
- Professor and Vice Chair Microbiology and Molecular Cell Biology, Microbiology and Molecular Cell Biology
Overview
overview
- David Taylor-Fishwick received his BSc (Hons) in Toxicology and Pharmacology at University of London, England whilst researching Interleukin-2 and the mechanism of action of the immunosuppressant drug Cyclosporine in Basel, Switzerland. He earned a PhD in Immunology at the Kennedy Institute of Rheumatology, Charing Cross Hospital and Royal Postgraduate Medical School, London, England. This thesis work studied cytokine identification, cytokine mechanisms of action and characterized cytokine receptor structure along with study of immunosuppressant drugs. Dr. Taylor-Fishwick developed an interest in cell signaling and T cell activation at the Immune Cell Biology Program, NNMC, Bethesda, MD. Dr. Taylor-Fishwick joined AstraZeneca plc, Loughborough, England progressing drug discovery in areas of T-subset immune modulation and immunosuppression. In 2000, Dr. Taylor-Fishwick joined the Diabetes Institutes at EVMS progressing a novel biological therapeutic for islet regeneration lead by Dr. Aaron Vinik from discovery to human clinical trials. Having identified an important immune interface that impedes islet regeneration, Dr. Taylor-Fishwick has continued funded studies at EVMS. These are focused on inflammatory factors and new drug discovery approaches to block the negative actions of inflammation. He is Vice-Chair and Professor in the Department of Microbiology and Molecular Cell Biology and is actively involved in Graduate Bioscience education and pre-clerkship Medical education.
Publications
selected publications
-
2019Role of the 12-lipoxygenase pathway in diabetes pathogenesis and complications. PHARMACOLOGY & THERAPEUTICS. 100-110.Full Text via DOI: 10.1016/j.pharmthera.2018.10.010 PMID: 30347209
-
2019Small molecule inhibition of NOX-1 reduces diabetes conversion in NOD mice. Integrative Molecular Medicine. 6.Full Text via DOI: 10.15761/imm.1000367
-
2018Evaluation of a human placenta-derived hydrogel to support glucose sensitive insulin secretion in human donor islets. Integrative Molecular Medicine. 5.Full Text via DOI: 10.15761/imm.1000339
-
2018Identification of a novel compound that protects beta cells and islets from dysfunction associated with inflammatory cytokines. Integrative Molecular Medicine. 5.Full Text via DOI: 10.15761/imm.1000329
-
201712-Lipoxygenase Inhibitor Improves Functions of Cytokine-Treated Human Islets and Type 2 Diabetic Islets. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 102:2789-2797.Full Text via DOI: 10.1210/jc.2017-00267 PMID: 28609824
-
2017Relationship of NADPH Oxidase-1 expression to beta cell dysfunction induced by inflammatory cytokines. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 485:290-294.Full Text via DOI: 10.1016/j.bbrc.2017.02.089 PMID: 28232183
-
2016Lipids and immunoinflammatory pathways of beta cell destruction.. DIABETOLOGIA. 673-8.Full Text via DOI: 10.1007/s00125-016-3890-y PMID: 26868492
-
2015Interleukin-12 (IL-12)/STAT4 Axis Is an Important Element for beta-Cell Dysfunction Induced by Inflammatory Cytokines. PLOS ONE. 10.Full Text via DOI: 10.1371/journal.pone.0142735 PMID: 26555476
-
2015Selective inhibition of 12-lipoxygenase protects islets and beta cells from inflammatory cytokine-mediated beta cell dysfunction. DIABETOLOGIA. 58:549-557.Full Text via DOI: 10.1007/s00125-014-3452-0 PMID: 25417214
-
2015Inhibition of NADPH oxidase-1 preserves beta cell function. DIABETOLOGIA. 58:113-121.Full Text via DOI: 10.1007/s00125-014-3398-2 PMID: 25277953
-
2015Role of NADPH Oxidase in Beta Cell Dysfunction. Islets of Langerhans, 2. ed.. 1-29.Full Text via DOI: 10.1007/978-94-007-6884-0_46-3
-
2015Inflammatory Pathways Linked to β Cell Demise in Diabetes. Islets of Langerhans. 989-1045.Full Text via DOI: 10.1007/978-94-007-6686-0_30
-
2014Synthesis and Structure-Activity Relationship Studies of 4-((2-Hydroxy-3-methoxybenzyl)amino)benzenesulfonamide Derivatives as Potent and Selective Inhibitors of 12-Lipoxygenase. JOURNAL OF MEDICINAL CHEMISTRY. 57:495-506.Full Text via DOI: 10.1021/jm4016476 PMID: 24393039
-
2013Interaction between cytokines and inflammatory cells in islet dysfunction, insulin resistance and vascular disease. DIABETES OBESITY & METABOLISM. 117-129.Full Text via DOI: 10.1111/dom.12161 PMID: 24003928
-
2013NOX, NOX Who is There? The Contribution of NADPH Oxidase One to Beta Cell Dysfunction.. FRONTIERS IN ENDOCRINOLOGY. 40.Full Text via DOI: 10.3389/fendo.2013.00040 PMID: 23565109
-
2013Production and function of IL-12 in islets and beta cells. DIABETOLOGIA. 56:126-135.Full Text via DOI: 10.1007/s00125-012-2732-9 PMID: 23052055
-
2013Deletion of 12/15-lipoxygenase alters macrophage and islet function in NOD-Alox15(null) mice, leading to protection against type 1 diabetes development.. PLOS ONE. 8:e56763.Full Text via DOI: 10.1371/journal.pone.0056763 PMID: 23437231
-
2013Regulation of NOX-1 expression in beta cells: a positive feedback loop involving the Src-kinase signaling pathway.. MOLECULAR AND CELLULAR ENDOCRINOLOGY. 369:35-41.Full Text via DOI: 10.1016/j.mce.2013.01.011 PMID: 23410839
-
2012Integration of pro-inflammatory cytokines, 12-lipoxygenase and NOX-1 in pancreatic islet beta cell dysfunction. MOLECULAR AND CELLULAR ENDOCRINOLOGY. 358:88-95.Full Text via DOI: 10.1016/j.mce.2012.03.004 PMID: 22502743
-
2011Discovery of Potent and Selective Inhibitors of Human Platelet-Type 12-Lipoxygenase. JOURNAL OF MEDICINAL CHEMISTRY. 54:5485-5497.Full Text via DOI: 10.1021/jm2005089 PMID: 21739938
-
2011Functional and pathological roles of the 12- and 15-lipoxygenases.. PROGRESS IN LIPID RESEARCH. 115-31.Full Text via DOI: 10.1016/j.plipres.2010.10.005 PMID: 20970452
-
2011Targeted expression of islet neogenesis associated protein to beta cells enhances glucose tolerance and confers resistance to streptozotocin-induced hyperglycemia.. MOLECULAR AND CELLULAR ENDOCRINOLOGY. 335:104-9.Full Text via DOI: 10.1016/j.mce.2010.12.026 PMID: 21187123
-
2010Harnessing the Pancreatic Stem Cell. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA. 39:763-+.Full Text via DOI: 10.1016/j.ecl.2010.08.008 PMID: 21095543
-
201012-Lipoxygenase Products Reduce Insulin Secretion and {beta}-Cell Viability in Human Islets.. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 95:887-93.Full Text via DOI: 10.1210/jc.2009-1102 PMID: 20089617
-
2010Pdx-1 Regulation of the INGAP Promoter Involves Sequestration of NeuroD Into a Non-DNA-Binding Complex. PANCREAS. 39:64-70.Full Text via DOI: 10.1097/mpa.0b013e3181baa0cc PMID: 19770784
-
2009A role for islet neogenesis in curing diabetes.. DIABETOLOGIA. 735-8.Full Text via DOI: 10.1007/s00125-009-1322-y PMID: 19271208
-
2009The role of islet neogeneis-associated protein (INGAP) in pancreatic islet neogenesis.. CURRENT PROTEIN & PEPTIDE SCIENCE. 37-45.Full Text via DOI: 10.2174/138920309787315211 PMID: 19275671
-
2008Transplantation and beyond. DRUG DEVELOPMENT RESEARCH. 69:165-176.Full Text via DOI: 10.1002/ddr.20242
-
2008Pancreatic islet immunoreactivity to the Reg protein INGAP.. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY. 56:183-91.Full Text via DOI: 10.1369/jhc.7a7365.2007 PMID: 17998566
-
2008The Reg family member INGAP is a marker of endocrine patterning in the embryonic pancreas.. PANCREAS. 36:1-9.Full Text via DOI: 10.1097/mpa.0b013r318148c8e6 PMID: 18192873
-
2007Intramuscular injection of islet neogenesis-associated protein peptide stimulates pancreatic islet neogenesis in healthy dogs.. PANCREAS. 34:103-11.Full Text via DOI: 10.1097/01.mpa.0000240609.56806.43 PMID: 17198191
-
2006PDX-1 can repress stimulus-induced activation of the INGAP promoter. JOURNAL OF ENDOCRINOLOGY. 188:611-621.Full Text via DOI: 10.1677/joe.1.06108 PMID: 16522740
-
2006Islet neogenesis associated protein transgenic mice are resistant to hyperglycemia induced by streptozotocin.. JOURNAL OF ENDOCRINOLOGY. 190:729-37.Full Text via DOI: 10.1677/joe.1.06698 PMID: 17003274
-
2005Monocarboxylate transporter MCT1 is a target for immunosuppression. Nature Chemical Biology. 1:371-376.Full Text via DOI: 10.1038/nchembio744 PMID: 16370372
-
2004A pentadecapeptide fragment of islet neogenesis-associated protein increases beta-cell mass and reverses diabetes in C57BL/6J mice.. ANNALS OF SURGERY. 240:875-84.Full Text via DOI: 10.1097/01.sla.0000143270.99191.10 PMID: 15492571
-
2004Advances in diabetes for the millennium: toward a cure for diabetes.. MedGenMed : Medscape general medicine. 12.PMID: 15647717
-
2004Stimulation of pancreatic islet neogenesis: a possible treatment for type 1 and type 2 diabetes. Current Opinion in Endocrinology & Diabetes. 11:125-140.Full Text via DOI: 10.1097/01.med.0000125482.65536.0a
-
2003Cloning genomic INGAP: a Reg-related family member with distinct transcriptional regulation sites.. Biochimica et biophysica acta. 1638:83-9.Full Text via DOI: 10.1016/s0925-4439(03)00042-5 PMID: 12757938
-
1998K21-antigen: a molecule shared by the microenvironments of the human thymus and germinal centers.. Developmental immunology. 41-52.Full Text via DOI: 10.1155/1998/29340 PMID: 9716904
-
1998The gp200-MR6 molecule which is functionally associated with the IL-4 receptor modulates B cell phenotype and is a novel member of the human macrophage mannose receptor family.. European journal of immunology. 28:4071-83.Full Text via DOI: 10.1002/(sici)1521-4141(199812)28:12<4071::aid-immu4071>3.0.co;2-o PMID: 9862343
-
1996Antigen receptor, structure and signaling in T cells. Lymphocyte Signalling: Mechanisms, Subversion and Manipulation. Ed. Harnett, M.
-
1995Interleukin-4 inhibits kappa light chain expression and NF kappa B activation but not I kappa B alpha degradation in 70Z/3 murine pre-B cells.. European journal of immunology. 25:2961-6.Full Text via DOI: 10.1002/eji.1830251037 PMID: 7589098
-
1995Raf-1 provides a dominant but not exclusive signal for the induction of CD69 expression on T cells. European journal of immunology. 25:3215-3221.Full Text via DOI: 10.1002/eji.1830251203 PMID: 8566003
-
1994Cytokine receptor signal transduction. Bailliere's Clinical Infectious Diseases. Ed. Griffin, G E.
-
1993Characterization of a novel high affinity human IL-7 receptor. Expression on T cells and association with IL-7 driven proliferation.. JOURNAL OF IMMUNOLOGY. 151:4753-63.PMID: 8409434
-
1993Evidence that rapamycin has differential effects of IL-4 function. Multiple IL-4 signaling pathways and implications for in vivo use.. Transplantation. 56:368-74.Full Text via DOI: 10.1097/00007890-199308000-00023 PMID: 7689258
-
1993Inhibition of activation-induced changes in the structure of the T cell interleukin-7 receptor by cyclosporin A and FK506.. European journal of immunology. 23:85-9.Full Text via DOI: 10.1002/eji.1830230114 PMID: 7678231
-
1992Activation induced changes in expression and structure of the IL-7 receptor on human T cells.. INTERNATIONAL IMMUNOLOGY. 4:277-82.Full Text via DOI: 10.1093/intimm/4.2.277 PMID: 1535786
-
1991Cloning, expression and cross-linking analysis of the murine p55 tumor necrosis factor receptor. European journal of immunology. 21:1649-1656.Full Text via DOI: 10.1002/eji.1830210710 PMID: 1647956
-
1991Interleukin 4 induces interleukin 6 production by endothelial cells: Synergy with interferon-γ. European journal of immunology. 21:97-101.Full Text via DOI: 10.1002/eji.1830210115 PMID: 1899386
-
1988Biotinylated recombinant interleukin-2. Journal of Immunological Methods. 113:221-229.Full Text via DOI: 10.1016/0022-1759(88)90335-3 PMID: 3262688
-
1988COMPARISON OF THE STRUCTURE OF THE MURINE INTERLEUKIN 2 (IL 2) RECEPTOR ON CYTOTOXIC AND HELPER T CELL LINES BY CHEMICAL CROSS-LINKING OF125I-LABELED IL 2. European journal of immunology. 18:1515-1519.Full Text via DOI: 10.1002/eji.1830181007
Research
research overview
-
Interests include (not limited to), immune modulation, T cell activation, inflammation, cell signaling, growth factors in disease and receptor/ligand interactions. Cell biology and assay development. Islet biology and cell regeneration. Diabetes and oxidative stress (NOX). Application of small molecule discovery and profiling mechanisms of action.
See current projects
projects
-
Current Project
-
Past Project
Contact
preferred title
- Professor and Vice Chair Microbiology and Molecular Cell Biology
full name
- David A. Taylor-Fishwick, PhD